Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer

被引:1
作者
Altundag, K [1 ]
Altundag, O
Morandi, P
Gunduz, M
机构
[1] Hacettepe Univ, Dept Med Oncol, Ankara, Turkey
[2] S Bortolo Gen Hosp, Dept Med Oncol, Vicenza, Italy
[3] Okayama Univ, Grad Sch Med & Dent, Dept Otolaryngol, Okayama, Japan
关键词
D O I
10.1016/j.urology.2004.06.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:211 / 212
页数:2
相关论文
共 3 条
[1]   Mechanisms of disease: Mechanisms of bone metastasis [J].
Roodman, GD .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (16) :1655-1664
[2]  
Santini D, 2003, CLIN CANCER RES, V9, P2893
[3]   Imatinib mesylate and zoledronic acid in an drogen-in dependent prostate cancer [J].
Tiffany, NM ;
Wersinger, EM ;
Garzotto, M ;
Beer, TM .
UROLOGY, 2004, 63 (05) :934-939